Some super-responders to specific cancer treatments likely have slow-growing tumors or cancers that are broadly sensitive to oncologic therapy, according to a first-of-its kind study. “So-called […]

A new model for prostate cancer screening can significantly reduce the number of unnecessary biopsies and minimize detection of clinically insignificant disease in comparison with standard […]

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for birch bark extract (Episalvan, Birken AG) for treatment […]